- Companies
June 6 (Reuters) – Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with routine care, according to study results.
The results were presented on Saturday at the American Diabetes Association.
Here are more details from the study:
Read more US eyes Iranian assets for Gulf allies’ reconstruction, source says
Read more North Korea will not retreat from nuclear status, Kim Jong Un’s sister says
Read more US budget carrier Breeze Airways sets sights on 2027 IPO
